trial · primary record
pp65 RNA LP (DP1)
Recurrent Pulmonary Osteosarcoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2035-10 |
| Primary endpoint | Maximum tolerated dose |
| Registry ID | NCT05660408 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:29.038Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05660408
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.